Calumet Analyst Price Targets - Benzinga

Calumet Inc

CLMTNASDAQ

Trade with Public

Trade with Public

$54.09

0.861.62%

Ult. Agg.: Sep 30, 10:40 AM

Panoramica Notizie Previsioni utili EventiObiettivi di prezzoDati finanziari Sentiment Azionariato Dividendi Confronta Opzioni Rapporto azionario

Calumet Analyst Price Targets

Wall Street analyst price targets and consensus rating for Calumet (CLMT).

Price Target Range — 11 Quarters

Analyst Consensus — 6 Analysts

3Buy

3Hold

Consensus RatingNeutral# Analysts6Avg. Consensus PT$41Upside to Avg. PT-25.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 2, 2026	HC Wainwright & Co.	Amit Dayal	PT Raise	Buy	$60→$75
Aug 25, 2026	UBS	Manav Gupta	PT Raise	Neutral	$26→$47
Aug 18, 2026	Goldman Sachs	Neil Mehta	PT Raise	Neutral	$40→$45
Aug 12, 2026	TD Cowen	Jason Gabelman	PT Raise	Hold	$34→$40
Jul 30, 2026	Goldman Sachs	Neil Mehta	PT Raise	Neutral	$36→$40
Mar 30, 2026	HC Wainwright & Co.	Amit Dayal	PT Raise	Buy	$33→$60
Mar 12, 2026	Goldman Sachs	Neil Mehta	PT Raise	Buy	$24→$34
Jan 30, 2026	Goldman Sachs	Neil Mehta	PT Raise	Buy	$20→$24
Nov 10, 2025	HC Wainwright & Co.	Amit Dayal	Maintained	Buy	$33
Oct 22, 2025	Goldman Sachs	Neil Mehta	PT Raise	Buy	$15→$20
Aug 12, 2025	UBS	Manav Gupta	PT Raise	Neutral	$12→$13
May 14, 2025	Wells Fargo	Roger Read	PT Cut	Overweight	$23→$21
May 13, 2025	B of A Securities	Conor Fitzpatrick	Initiate	Buy	$15
Apr 30, 2025	Goldman Sachs	Neil Mehta	PT Cut	Buy	$16→$14
Apr 9, 2025	Wells Fargo	Roger Read	PT Cut	Overweight	$28→$23
Mar 17, 2025	UBS	Manav Gupta	Upgrade	Sell→Neutral	$15→$12
Mar 5, 2025	Wells Fargo	Roger Read	PT Cut	Overweight	$29→$28
Mar 3, 2025	HC Wainwright & Co.	Amit Dayal	Maintained	Buy	$33
Feb 12, 2025	HC Wainwright & Co.	Amit Dayal	Maintained	Buy	$33
Feb 4, 2025	UBS	Manav Gupta	Downgrade	Neutral→Sell	$21→$15

More with Benzinga EdgeGet Access

Analyst Ratings News

Salesforce To Rally More Than 16%? Here Are 10 Top Analyst Forecasts For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Cantor Fitzgerald raised

Avi Kapoor

PRO
HC Wainwright & Co. Maintains Buy on Calumet, Raises Price Target to $75

HC Wainwright & Co. analyst Amit Dayal maintains Calumet (NASDAQ:CLMT) with a Buy and raises the price target from $60 to $75.

Benzinga Newsdesk

PRO
UBS Maintains Neutral on Calumet, Raises Price Target to $47

UBS analyst Manav Gupta maintains Calumet (NASDAQ:CLMT) with a Neutral and raises the price target from $26 to $47.

Benzinga Newsdesk

PRO
Goldman Sachs Maintains Neutral on Calumet, Raises Price Target to $45

Goldman Sachs analyst Neil Mehta maintains Calumet (NASDAQ:CLMT) with a Neutral and raises the price target from $40 to $45.

Benzinga Newsdesk

PRO
TD Cowen Maintains Hold on Calumet, Raises Price Target to $40

TD Cowen analyst Jason Gabelman maintains Calumet (NASDAQ:CLMT) with a Hold and raises the price target from $34 to $40.

Benzinga Newsdesk

PRO
Goldman Sachs Maintains Neutral on Calumet, Raises Price Target to $40

Goldman Sachs analyst Neil Mehta maintains Calumet (NASDAQ:CLMT) with a Neutral and raises the price target from $36 to $40.

Benzinga Newsdesk